Amy Lynn Corneli, PhD

Associate Professor in Population Health Sciences
Associate Professor in Medicine
Associate of the Duke Initiative for Science & Society
Affiliate, Duke Global Health Institute
member of the Duke Clinical Research Institute
Campus mail 215 Morris Street, Durham, NC 27701
Phone (919) 668-9238
Email address amy.corneli@duke.edu

A social scientist by training, Dr. Corneli has conducted qualitative and mixed-method research primarily in biomedical HIV prevention and bioethics in multiple countries in sub-Saharan Africa, the Middle East, South and Southeast Asia, and in the U.S.  A significant portion of her research portfolio has focused on engaging patients/participants and other key stakeholders in qualitative research to inform clinical research, socio-behavioral interventions, and material and scale/questionnaire development as well as to assess participant perceptions of intervention/clinical trial implementation. Her HIV-related research focuses on identifying evidence-based strategies for linking populations at HIV risk to PrEP care, support PrEP adherence to achieve protective levels, and keep clients engaged in PrEP care for as long as their HIV risk persists. Her research in bioethics has explored innovative methods for improving informed consent comprehension and shortening consent forms, the acceptability of informed assent, and the functioning of research ethics committees.

Areas of expertise: HIV, qualitative research methods, bioethics, health behavior

Education and Training

  • Fellow, Center for Disease Control, 1997 - 2000
  • Ph.D., University of North Carolina at Chapel Hill, 2004
  • M.P.H., Emory University, 1995

Publications

Dombeck, Carrie B., Terri Hinkley, Christopher B. Fordyce, Katelyn Blanchard, Matthew T. Roe, and Amy Corneli. “Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials.” Contemp Clin Trials Commun 17 (March 2020): 100502. https://doi.org/10.1016/j.conctc.2019.100502.

PMID
31890985
Full Text

Fordyce, Christopher B., Kaitlin Malone, Annemarie Forrest, Terri Hinkley, Amy Corneli, James Topping, and Matthew T. Roe. “Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative.” Contemp Clin Trials Commun 16 (December 2019): 100462. https://doi.org/10.1016/j.conctc.2019.100462.

PMID
31701037
Full Text

Perry, Brian, Cindy Geoghegan, Li Lin, F Hunter McGuire, Virginia Nido, Brigid Grabert, Steve L. Morin, Zachary P. Hallinan, and Amy Corneli. “Patient preferences for using mobile technologies in clinical trials.” Contemp Clin Trials Commun 15 (September 2019): 100399. https://doi.org/10.1016/j.conctc.2019.100399.

PMID
31312746
Full Text

Corneli, Amy, Karen Meagher, Gail Henderson, Holly Peay, and Stuart Rennie. “How Biomedical HIV Prevention Trials Incorporate Behavioral and Social Sciences Research: A Typology of Approaches.” Aids Behav 23, no. 8 (August 2019): 2146–54. https://doi.org/10.1007/s10461-018-2358-0.

PMID
30535615
Full Text

Apostolaros, M., D. Babaian, A. Corneli, A. Forrest, G. Hamre, J. Hewett, L. Podolsky, V. Popat, and P. Randall. “Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative.” Therapeutic Innovation and Regulatory Science, January 1, 2019. https://doi.org/10.1007/s43441-019-00006-4.

Full Text

Wheeler, Sarahn M., Kelley E. C. Massengale, Katelyn P. Blanchard, Thelma A. Fitzgerald, Teresa Swezey, Geeta K. Swamy, and Amy Corneli. “Improving Uptake and Adherence to 17-Hydroxyprogesterone Caproate in Non-Hispanic Black Women: A Mixed Methods Study of Potential Interventions from the Patient Perspective.” Biores Open Access 8, no. 1 (2019): 155–61. https://doi.org/10.1089/biores.2019.0010.

PMID
31649831
Full Text

Corneli, Amy, Brian Perry, Deborah Collyar, John H. Powers, John J. Farley, Sara B. Calvert, Jonas Santiago, et al. “Assessment of the Perceived Acceptability of an Early Enrollment Strategy Using Advance Consent in Health Care-Associated Pneumonia.” Jama Netw Open 1, no. 8 (December 7, 2018): e185816. https://doi.org/10.1001/jamanetworkopen.2018.5816.

PMID
30646295
Full Text

Grodensky, Catherine A., Carol E. Golin, Allison P. Pack, Audrey Pettifor, Michele Demers, Cecelia Massa, Gift Kamanga, Kevin McKenna, and Amy Corneli. “Adaptation and delivery of a motivational interviewing-based counseling program for persons acutely infected with HIV in Malawi: Implementation and lessons learned.” Patient Educ Couns 101, no. 6 (June 2018): 1103–9. https://doi.org/10.1016/j.pec.2018.02.004.

PMID
29519656
Full Text

Greenberg, Rachel G., Amy Corneli, John Bradley, John Farley, Hasan S. Jafri, Li Lin, Sumathi Nambiar, et al. “Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative.” Contemp Clin Trials Commun 9 (March 2018): 7–12. https://doi.org/10.1016/j.conctc.2017.11.006.

PMID
29696219
Full Text

Corneli, Amy, Chris Wheeler, John Bradley, Breck Gamel, Sumathi Nambiar, Gary J. Noel, Li Lin, Jamie N. Roberts, and Daniel K. Benjamin. “Facilitators and barriers to the successful implementation of pediatric antibacterial drug trials: Findings from CTTI's survey of investigators.” Contemp Clin Trials Commun 9 (March 2018): 115–20. https://doi.org/10.1016/j.conctc.2018.01.003.

PMID
29696233
Full Text

Pages